Apr 29 |
UPDATE 2-Annovis tumbles as Alzheimer's treatment misses in mid-stage study
|
Apr 29 |
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease
|
Apr 27 |
FOMC Meeting, Jobs Report, And Apple Earnings Headline Big Week
|
Apr 24 |
Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade
|
Apr 23 |
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
|
Apr 19 |
Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
|
Apr 19 |
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
|
Apr 18 |
DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch
|
Apr 17 |
Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals
|
Apr 16 |
Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
|